Assessing medication adherence by pill count and electronic monitoring in the African American study of kidney disease and hypertension (AASK) pilot study

American Journal of Hypertension

Volumn 9, Issue 8 I, 1996, Pages 719-725

  Lee, Jeannette Y ^a   Kusek, John W ^b   Greene, Paul G ^c   Bernhard, Steve ^d   Morris, Keith ^e   Smith, Delia ^f   Wilkening, Beth ^a   Wright Jr , Jackson T ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^d EMORY UNIVERSITY   (United States)

^e CASE WESTERN RESERVE UNIVERSITY   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Antihypertensive drugs; Compliance; Medication Event Monitoring System (MEMS)

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; ENALAPRIL; FUROSEMIDE; HYDRALAZINE; MINOXIDIL;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0029783066     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-7061(96)00056-8     Document Type: Article

References (33)

1. Rudd P, Ahmed S, Zachary V, et al: Issues in patient compliance: the search for therapeutic sufficiency. Cardiology 1992;80(suppl 1):2-10.
2. Horwitz RI, Viscoli CM, Berkman L, et al: Treatment adherence and risk of death after a myocardial infarction. Lancet 1990;336:542-545.
3. Gallagher EJ. Viscoli CM, Horwitz RI: The relationship of treatment adherence to the risk of death after myocardial infarction in women. JAMA 1993;270(6):742-744.
4. Coronary Drug Project Research Group: Influence of adherence to treatment and response of cholesterol on mortality in the Coronary Drug Project. N Engl J Med 1980;303:1038-1041.
5. Pullar T, Kumar S, Feely M: Compliance in clinical trials. Ann Rheum Dis 1989;48:871-875.
6. Cramer JA, Mattson RH, Prevey ML, et al: How often is medication taken as prescribed? JAMA 1989;261:3273-3277.
7. Rudd P, Marshall G: Resolving problems of measuring compliance with medication monitors. Journal of Compliance in Health Care 1987;2(1):23-35.
8. Rudd P, Byyny RL, Zachary V, et al: The natural history of medication compliance in a drug trial: limitations of pill counts. Clin Pharmacol Ther 1989;46(2):169-176.
9. Pullar T, Birtwell AJ, Wiles PG, et al: Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily. Clin Pharmacol Ther 1988;44(5):540-545.
10. Pullar T, Feely M: Problems of compliance with drug treatment: new solutions? Pharm J 1990;245:213-215.
11. Rand CS, Wise RA, Nides M, et al: Metered-dose inhaler adherence in a clinical trial. Am Rev Respir Dis 1992;146:1559-1564.
12. Rudd P, Ramesh J, Bryant-Kosling C, Guerrero D: Gaps in cardiovascular medication taking: the tip of the iceberg. J Gen Intern Med 1993;8:656-666.
13. Stephenson BJ, Rowe BH, Haynes RB, et al: Is this patient taking the treatment as prescribed? JAMA 1993;269(21):2779-2781.
14. Pullar T, Kumar S, Tindall H, Feely M: Time to stop counting tablets? Clin Pharmacol Ther 1989;46(2):163-168.
15. Cramer JA, Scheyer RD, Mattson RH: Compliance declines between clinic visits. Arch Internal Med 1990;150:1509-1510.
16. Bond WS, Hussar DA: Detection methods and strategies for improving medication comp1iance. Am J Hosp Pharm 1991;48:1978-1988.
17. Clark LT: Improving compliance and increasing control of hypertension: needs of special hypertensive populations. Am Heart J 1991;121:664-669.
18. Shea S, Misra D, Ehrlich MH, et al: Correlates of nonadherence to hypertension treatment in an inner-city minority population. Am J Public Health 1992;82(12): 1607-1612.
19. Furberg CD, Black DM for the SHEP Research Group: The systolic hypertension in the elderly pilot program: methodological issues. Eur Heart J 1988;9:223-227.
20. Shulman N, Cutter G, Daugherty R, et al: Correlates of attendance and compliance in the Hypertension Detection and Follow-up Program. Controlled Clin Trials 1982;3:13-27.
21. Connett JE, Stamler J: Responses of black and white mates to the special intervention program of the Multiple Risk Factor Intervention Trial. Am Heart J 1984;108:839-849.
22. Wright JT, Jr., Kirk KA, Kusek JW, et al: Design of the African-American Study of Kidney Disease and Hypertension (AASK) Pilot Study (abst). J Am Soc Nephrol 1994;5(3):570.
23. Lee JY, Greene PG, Douglas M, et al: Appointment attendance, pill counts, and achievement of target blood pressure in the African American Study of Kidney Disease and Hypertension. Controlled Clin Trials (in press).
24. Whelton P, Lee J, Kopple J, et al, for the AASK Pilot Investigators: Recruitment in the African American Study of Kidney Disease and Hypertension (AASK) (abst). J Am Soc Nephrol 1994;5(3):570.
25. Breyer JA, Toto RD, Hall WD, et al, for the AASK Pilot Investigators: Baseline characteristics of patients entering the pilot African-American Study of Kidney Disease (Pilot-AASK) (abst). J Am Soc Nephrol 1994;5(3):557.
26. Rudd P, Ahmed S, Zachary V, et al: Improved compliance measures: applications in an ambulatory hypertensive drug trial. Clin Pharmacol Ther 1990;48:679-685.
27. Fleiss JL: Statistical Methods for Rates and Proportions, 2nd Ed. John Wiley & Sons, New York, 1981.
28. Treatment of Mild Hypertension Study Group: The Treatment of Mild Hypertension Study. Arch Intern Med 1991;151:1413-1423.
29. Eisen SA, Woodward RS, Miller D, et al: The effect of medication compliance on the control of hypertension. J Gen Intern Med 1987;2:298-305.
30. Guerrero D, Rudd P, Bryant-Kosling C, Middleton BF: Antihypertensive medication-taking. Am J Hypertens 1993;6:586-592.
31. Nides MA, Tashkin DP, Simmons MS, et al: Improving inhaler adherence in a clinical trial through the use of the nebulizer chronolog. Chest 1993;104(2):501-507.
32. McKenney JM, Munroe WP, Wright JT, Jr.: Impact of an electronic medication compliance aid on long-term blood pressure control. J Clin Pharmacol 1992;32:277-283.
33. Lazarus JM, Bourgoignie JJ, Buckale VM, et al, for the Modification of Diet in Renal Disease Study Group: Achievement of blood pressure goals and safety of the blood pressure interventions in the Modification of Diet in Renal Disease Study. (Submitted).